OBV/PTV/r +/- DSV in HCV GT4-infected Patients With Severe CKD OBV/PTV/r +/- DSV in HCV GT4-infected Patients With Severe CKD

This study investigated the real-world efficacy of ombitasvir/paritaprevir/ritonavir +/- DSV regimen in HCV genotypes 4 and 1 patients with advanced chronic kidney disease.Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news